Article ID Journal Published Year Pages File Type
8668360 Journal of Clinical Lipidology 2018 5 Pages PDF
Abstract
Two months of treatment with evolocumab 140 mg may improve endothelial function in subjects with increased cardiovascular risk. The improvement in endothelial function is proportional to LDL reduction.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , , ,